HomeADPT • NASDAQ
Adaptive Biotechnologies Corp
add
$11.98
12.49%
Pre-market:(0.50%)+0.060
$12.04
Closed: Jun 26, 12:30:34 AM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 52.44M | 25.24% |
Operating expense | 65.07M | -10.35% |
Net income | -29.85M | 37.16% |
Net profit margin | -56.92 | 49.83% |
Earnings per share | -0.20 | 37.25% |
EBITDA | -24.87M | 42.88% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 193.42M | -37.38% |
Total assets | 510.85M | -17.65% |
Total liabilities | 320.63M | -7.21% |
Total equity | 190.22M | — |
Shares outstanding | 151.92M | — |
Price to book | 8.52 | — |
Return on assets | -14.09% | — |
Return on capital | -17.71% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -29.85M | 37.16% |
Cash from operations | -28.48M | 25.73% |
Cash from investing | 25.57M | -42.54% |
Cash from financing | 5.45M | 12,288.64% |
Net change in cash | 2.54M | -59.03% |
Free cash flow | -17.92M | 14.65% |
Previous close
$10.65
Day range
$10.62 - $12.07
Year range
$3.26 - $12.07
Market cap
1.82B USD
Avg Volume
1.32M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
CEO
Founded
2009
Headquarters
Website
Employees
619
